Hong Kong/China M&A/Events

Hong Kong/China M&A/Events

Hang Lung (10 HK) Is Still Inexpensive. Lack Of Liquidity Not Helping

Quiddity Research's avatar
Quiddity Research
Feb 24, 2026
∙ Paid
  • Back in January 2024, Hang Lung Properties (101 HK) (HLP) offered a scrip dividend option for FY23, a first for the company. Scrip dividends have been afforded ever since.

  • HLP’s major shareholder, Hang Lung (10 HK), has taken full advantage of this option, increasing its stake by 4%; and potentially up to 5% when factoring in FY25 dividends.

  • Interestingly, the implied stub has widened since the commencement of scrip dividends, with the market assigning HK$600mn less for the stub ops.

The Trade:

  • HLG is cheap (0.23x P/B), albeit illiquid.

  • Expect HLG to continue to exercise its rights to HLP scrip for the foreseeable future.

  • There may some grand plan afoot.

  • But I’d still be cautious jumping into either HLG or HLP in a major way.

This insight is labelled bullish, as I’m not bearish.

Keep reading with a 7-day free trial

Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 Quiddity Investment Advisors · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture